Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and

Alexey Yumashev1, Rizaev Jasur2, Muazzamov Baxodir3

  • 1Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia.

Seminars in Oncology
|August 20, 2026
PubMed

Insights

Silver nanoparticles (AgNPs) show promise for cancer treatment by targeting the tumor microenvironment (TME). Further research is needed to address AgNP toxicity, environmental impact, and clinical application challenges.

Area of Science:

  • Oncology
  • Nanomedicine
  • Materials Science

Background:

  • Cancer is a major global health challenge driven by genetic and epigenetic changes.
  • The tumor microenvironment (TME) is critical for cancer progression, immune evasion, and metastasis.
  • Modulating the TME is a key strategy for cancer prevention and therapy.

Purpose of the Study:

  • To review the features and components of the TME.
  • To explain the synthesis and mechanisms of action of silver nanoparticles (AgNPs).
  • To contextualize AgNPs' applications in nanomedicine and cancer treatment.

Main Methods:

  • Literature review of TME characteristics.
  • Analysis of AgNP synthesis and mechanisms.
  • Synthesis of existing research on AgNPs in cancer therapy.

Main Results:

  • AgNPs exhibit anticancer properties through oxidative stress, impaired intracellular mechanisms, and immune signaling modulation.
  • AgNPs demonstrate potential in nanomedicine for cancer treatment.
  • The review synthesizes current understanding of AgNPs' role in targeting the TME.

Conclusions:

  • AgNPs show promising anticancer activity by interacting with the TME.
  • Key areas for future research include AgNP toxicity, environmental risks, and clinical translation.
  • Further investigation is required to fully realize the therapeutic potential of AgNPs in oncology.